Faith Reidenbach


Antithrombotic Therapy for the Prevention of Secondary Coronary Artery Disease

August 16, 2019

The advent of newer antiplatelet agents and oral anticoagulants has allowed new regimens for secondary prevention of coronary artery disease. When combination therapy is needed, the bleeding risk is particularly pronounced, and the benefits and risks must be balanced for individual patients.